Palvella Therapeutics, Inc. (PVLA): Cash & Equivalents
$57.98M
As of 2025-12-31
$187.80M
As of 2026-06-30
+14.5%
3-year compound annual growth
-3.8%
5-year compound annual growth
+7.0%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $57.98M | -30.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $83.60M | n/m | 2026-03-31, Balance as of period end |
| 2023-12-31 | $7.35M | -81.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $38.63M | -67.2% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $117.76M | +67.2% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $70.44M | +13.1% | 2022-03-02, Balance as of period end |
| 2019-12-31 | $62.26M | -16.8% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $74.87M | +97.7% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $37.88M | +29.0% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $29.36M | 0.0% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $29.35M | +58.9% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $18.47M | n/a | 2016-03-23, Balance as of period end |
| 2014-06-30 | $11.1K | n/a | 2014-09-12, Balance as of period end |
| 2013-12-31 | $3.69M | n/a | 2015-03-30, Balance as of period end |
| 2013-06-30 | $5.2K | n/a | 2014-09-12, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | 2025-12-31 | $57.98M | -30.6% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $90.0K | -86.7% |
| ALX Oncology Holdings Inc (ALXO) | 2025-12-31 | $16.37M | -6.8% |
| Scynexis Inc (SCYX) | 2025-12-31 | $21.26M | +32.4% |
| Pasithea Therapeutics Corp. (KTTA) | 2025-12-31 | $55.16M | +696.8% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $18.62M | +394.9% |
| Biomea Fusion, Inc. (BMEA) | 2025-12-31 | $55.81M | -4.2% |
| DiaMedica Therapeutics Inc. (DMAC) | 2025-12-31 | $15.65M | +417.3% |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $48.30M | -38.1% |
Compare PVLA, PRPH, ALXO, SCYX side by side · Screen every company in Pharmaceutical Preparations ↗